XML 23 R16.htm IDEA: XBRL DOCUMENT v3.24.3
Financing Arrangements
6 Months Ended
Oct. 25, 2024
Debt Disclosure [Abstract]  
Financing Arrangements

6. Financing Arrangements

Long-Term Debt

The following table summarizes information relating to our long-term debt, which we collectively refer to as our Senior Notes (in millions, except interest rates):

 

 

Effective Interest Rate

 

October 25,
 2024

 

 

April 26,
  2024

 

3.30% Senior Notes Due September 2024

 

3.42%

 

$

 

 

$

400

 

1.875% Senior Notes Due June 2025

 

2.03%

 

 

750

 

 

 

750

 

2.375% Senior Notes Due June 2027

 

2.51%

 

 

550

 

 

 

550

 

2.70% Senior Notes Due June 2030

 

2.81%

 

 

700

 

 

 

700

 

Total principal amount

 

 

 

 

2,000

 

 

 

2,400

 

Unamortized discount and issuance costs

 

 

 

 

(7

)

 

 

(8

)

Total senior notes

 

 

 

 

1,993

 

 

 

2,392

 

Less: Current portion of long-term debt

 

 

 

 

(749

)

 

 

(400

)

Total long-term debt

 

 

 

$

1,244

 

 

$

1,992

 

 

Senior Notes

On September 30, 2024, upon maturity, we repaid the 3.30% Senior Notes due September 2024 for an aggregate amount of $407 million, comprised of the principal and unpaid interest. Interest on our outstanding Senior Notes is payable semi-annually in June and December.

Our Senior Notes, which are unsecured, unsubordinated obligations, rank equally in right of payment with any existing and future senior unsecured indebtedness.

We may redeem the Senior Notes in whole or in part, at any time at our option at specified redemption prices. In addition, upon the occurrence of certain change of control triggering events, we may be required to repurchase the Senior Notes under specified terms. The Senior Notes also include covenants that limit our ability to incur debt secured by liens on assets or on shares of stock or indebtedness of our subsidiaries; to engage in certain sale and lease-back transactions; and to consolidate, merge or sell all or substantially all of our assets. As of October 25, 2024, we were in compliance with all covenants associated with the Senior Notes.

As of October 25, 2024, our aggregate future principal debt maturities are as follows (in millions):

Fiscal Year

 

Amount

 

2025 (remainder)

 

$

 

2026

 

 

750

 

2027

 

 

 

2028

 

 

550

 

2029

 

 

 

Thereafter

 

 

700

 

Total

 

$

2,000

 

Commercial Paper Program and Credit Facility

We have a commercial paper program (the “Program”), under which we may issue unsecured commercial paper notes. Amounts available under the Program, as amended in July 2017, may be borrowed, repaid and re-borrowed, with the aggregate face or principal amount of the notes outstanding under the Program at any time not to exceed $1.0 billion. The maturities of the notes can vary, but may not exceed 397 days from the date of issue. The notes are sold under customary terms in the commercial paper market and may be issued at a discount from par or, alternatively, may be sold at par and bear interest at rates dictated by market conditions at the time of their issuance. The proceeds from the issuance of the notes are used for general corporate purposes. There were no commercial paper notes outstanding as of October 25, 2024 or April 26, 2024.

 

In connection with the Program, we have a senior unsecured credit agreement with a syndicated group of lenders. The credit agreement, which was amended in May 2023, provides for a $1.0 billion revolving unsecured credit facility, with a sublimit of $50 million available for the issuance of letters of credit on our behalf. The credit facility matures on January 22, 2026, with an option for us to extend the maturity date for two additional 1-year periods, subject to certain conditions. The proceeds of the loans may be used by us for general corporate purposes and as liquidity support for our existing commercial paper program. As of October 25, 2024, we were compliant with all associated covenants in the agreement. No amounts were drawn against this credit facility during any of the periods presented.